EUVIMEDEUVIMED entdecken
Crossref

Anti‐Inflammatory Pharmacodynamic Basis and Mechanism of QianLieXin Capsule in Chronic Prostatitis: Insights From Absorbed Components and Network Pharmacology

Cejia Liu, Linghe Zang, Yuwei Zhang, Yang Wang, Yi Qin, Huiqi Wen, Jiaxin Ma, Ruihua Sui, Jiaxin Sun, Jiahang Yu, Zhaoqing Meng, Tao Shen iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Cejia Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Prostatitis, Drugs, Chinese Herbal. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Career Development Support Program for Young and Middle-aged Teachers of Shenyang Pharmaceutical University, Project of Quancheng "5150" talent introduction and multiplication plan innovative talents, National Key R & D Program for the 13th Five-year Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to further clarify the material basis and mechanism of the QianLieXin (QLX) capsule. UPLC‐Q‐MS was employed to identify the active substances absorbed into the blood and prostate. Pharmacological network analysis and anti‐inflammatory assays were performed. Twenty principal bioactive compounds of the QLX capsule were identified in the blood and prostate tissues of rats. Network pharmacology and molecular docking analyses demonstrated 292 potential targets of these active substances relevant to the treatment of chronic prostatitis. Among them, chlorogenic acid, apigenin, kaempferol, isoquercitrin, and ursolic acid were identified as the primary agents exerting anti‐inflammatory effects. The principal molecular targets included AKT1, EGFR, PIK3, and MAPK, among others. Key signaling pathways encompassed the neuroligin‐receptor interaction pathway as well as lipid metabolism and atherosclerosis‐related pathways. Experimental results demonstrated that both the medicated serum and the active substances significantly suppressed lipopolysaccharide‐induced interleukin‐1β levels, inhibited the expression of NF‐κB protein, and reduced reactive oxygen species production, indicating notable anti‐inflammatory and antioxidant activities. Furthermore, QLX has a strong binding effect on targets such as EGFR, AKT, and MMP9. Medicated serum was shown to downregulate the EGFR/AKT/MAPK/MMP9 signaling pathways. Our findings clarified the pharmacodynamic substances of the multicomponent QLX capsule and its regulatory mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory AgentsProstatitisDrugs, Chinese HerbalAnimalsMaleNetwork PharmacologyRatsRats, Sprague-DawleyMolecular Docking SimulationChromatography, High Pressure LiquidChronic DiseaseSignal Transduction

Stichwörter der Autor:innen

QianLieXin capsuleanti‐inflammationmaterial basisnetwork pharmacology

Substanzen

Anti-Inflammatory AgentsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.
  • Institute of Traditional Chinese Medicine, Shandong Hongjitang Pharmaceutical Group Co. Ltd, Jinan, Shandong Province, China.

ORCID-Profile: Tao Shen

Förderung

  • Career Development Support Program for Young and Middle-aged Teachers of Shenyang Pharmaceutical University
  • Project of Quancheng "5150" talent introduction and multiplication plan innovative talents
  • National Key R & D Program for the 13th Five-year Plan

Zitieren

APA

Liu, C., Zang, L., Zhang, Y., Wang, Y., Qin, Y., Wen, H., Ma, J., Sui, R., Sun, J., Yu, J., Meng, Z., & Shen, T. (2026). Anti‐Inflammatory Pharmacodynamic Basis and Mechanism of QianLieXin Capsule in Chronic Prostatitis: Insights From Absorbed Components and Network Pharmacology. Biomedical Chromatography. https://doi.org/10.1002/bmc.70256

Vancouver

Liu C, Zang L, Zhang Y, Wang Y, Qin Y, Wen H, et al. Anti‐Inflammatory Pharmacodynamic Basis and Mechanism of QianLieXin Capsule in Chronic Prostatitis: Insights From Absorbed Components and Network Pharmacology. Biomedical Chromatography. 2026. doi:10.1002/bmc.70256

BibTeX
@article{Liu2026,
  author = {Liu, Cejia and Zang, Linghe and Zhang, Yuwei and Wang, Yang and Qin, Yi and Wen, Huiqi and Ma, Jiaxin and Sui, Ruihua and Sun, Jiaxin and Yu, Jiahang and Meng, Zhaoqing and Shen, Tao},
  title = {Anti‐Inflammatory Pharmacodynamic Basis and Mechanism of QianLieXin Capsule in Chronic Prostatitis: Insights From Absorbed Components and Network Pharmacology},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70256}
}
Kostenlos starten →